DeepCurrents Investment Group LLC - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 49 filers reported holding IBERE PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
DeepCurrents Investment Group LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$178,896
+1.6%
17,7300.0%0.01%0.0%
Q3 2022$176,000
+1.1%
17,7300.0%0.01%0.0%
Q2 2022$174,0000.0%17,7300.0%0.01%
+40.0%
Q1 2022$174,000–17,730–0.01%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q3 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders